ImmuneSpec
PrivateLast Round
Seed
Mar 24, 2023
Total Funding Raised
$1.3M
Company Overview
ImmuneSpec is a biotechnology company that provides high-sensitivity immunopeptidomics analysis services for the development of vaccines, immunotherapeutics, and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneSpec Comparables
Compare ImmuneSpec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pure MHC, LLC | 78% | |
| Bruker | 76% | |
| MS Bioworks | 74% |
ImmuneSpec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2023 |
Key People
Founding team and executive leadership
ImmuneSpec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HERAN Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2025
Grew 33% QoQ from 9 to 12 employees.
- Mar 24, 2023
$1.3M round led by HERAN Partners
ImmuneSpec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmuneSpec's valuation, stock price, and market status.
Is ImmuneSpec a public or private company?
ImmuneSpec is a private company.
What is the current stock price of ImmuneSpec?
ImmuneSpec is a private company with no public stock price. No recent secondary market data is available.
How much is ImmuneSpec worth (valuation)?
Valuation information for ImmuneSpec is not publicly available.
Can I buy ImmuneSpec stock?
ImmuneSpec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmuneSpec's last funding round?
ImmuneSpec's most recent funding round was Seed on March 24, 2023.
Who are the main investors in ImmuneSpec?
Key investors in ImmuneSpec include HERAN Partners.
Will ImmuneSpec IPO soon?
No public IPO plans have been announced for ImmuneSpec.
How can I track ImmuneSpec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmuneSpec's secondary market activity and sign up for updates.